Abstract:Introduction: The underlying molecular mechanisms responsible for omega-3 PUFAs’ biological effects are mediated by the production of pro-resolving mediators, which have been proposed to modulate and likely resolve inflammatory responses. The anti-inflammatory action of dietary omega-3-polyunsaturated fatty acid supplementation in animal models has been studied using membrane stabilization and vascular permeability methods. This study is, therefore, focused on the long-term therapeutic safety and efficacy of fish oil supplements as a safer alternative to traditional NSAIDs. Also, whether these methods serve as mechanisms of antiinflammation has been confirmed further. Method: Animals were distributed in six groups of five each (n = 5). Group 1 was administered 300mg/ml omega-3 fatty acids (n-3 FA) containing 180mg/ml EPA and 120mg/ml DHA; group 2 received 600mg/ml n-3 FA containing 360mg/ml EPA and 240mg/ml DHA; group 3 received 900mg/ml n-3 FA containing 540mg/ml EPA and 360mg/ml DHA; group 4 was administered 300mg/ml of the fish oil along with 20mg/ml celecoxib; group 5 was given 20mg/ml celecoxib that represented the positive control, and group 6 was administered 2 ml phosphate buffer saline alone, which served as the vehicle control group. Membrane stabilization of the rat’s red blood cells and aceticacid-induced vascular permeability were assayed. The percentage inhibition was determined. The analysis was performed using GraphPad InStat version 5 software and subjected to the Bonferroni test for the separation of means. Result: The results of membrane stabilization assays exhibited 30.59%, 27.70%, 49.63%, 55.41%, 57.28%, and 13.13% inhibitions, and vascular permeability inhibitions were found to be 80.05%, 53.27%, 74.31%, 86.33%, and 90.43%, respectively. The results provide scientific evidence for the use of dietary omega-3-polyunsaturated fatty acid as a food supplement capable of resolving inflammatory conditions without side effects produced by traditional NSAIDs. Conclusion: The restoration of altered membrane permeability and vasculature is a testament to the efficacy of omega-3 as an anti-inflammatory agent and indeed shows these methods as anti-inflammatory mechanisms. The bioactive components in omega-3 PUFAs, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in fish oil are capable of interrupting the prostaglandin metabolic pathway by competing with arachidonic acids for the COX active site, thereby inhibiting their synthesis.

Liposomal Formulations Enhance the Anti-Inflammatory Effect of Eicosapentaenoic Acid in HL60 Cells

Membrane Stabilization and Vascular Permeability as Mechanisms for the Evaluation of Anti-inflammatory Action of Omega-3-poly Unsaturated Fatty Acid Oil Extract

Effect of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) on the regulation of vascular endothelial cell function

Effects of eicosapentaenoic acid on inflammatory cytokine secretion in endothelial cells stimulated by lipopolysaccharide

Effects of Fatty Acid-Ethanol Amine (FA-EA) Derivatives on Lipid Accumulation and Inflammation.

Effect Of Marine-Derived N-3 Polyunsaturated Fatty Acids On Major Eicosanoids: A Systematic Review And Meta-Analysis From 18 Randomized Controlled Trials

Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages

Protective Role of Eicosapentaenoic and Docosahexaenoic and Their N-Ethanolamide Derivatives in Olfactory Glial Cells Affected by Lipopolysaccharide-Induced Neuroinflammation

15-Lipoxygenase metabolites of α-linolenic acid, [13-(S)-HPOTrE and 13-(S)-HOTrE], mediate anti-inflammatory effects by inactivating NLRP3 inflammasome

Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During Inflammation

Anti-inflammatory effect of a novel piperazino-enaminone delivered by liposomes in a mouse model of hemophilic arthropathy

Hot-Melt Extrusion Drug Delivery System-Formulated Haematococcus pluvialis Extracts Regulate Inflammation and Oxidative Stress in Lipopolysaccharide-Stimulated Macrophages

The Anti-Inflammatory Effect of Ent-Kaur-15-en-17-al-18-oic Acid on Lipopolysaccharide-Stimulated RAW264.7 Cells Associated with NF-κB and P38/MAPK Pathways.

Anti-inflammatory activity of algal oils containing Docosahexaenoic Acid (DHA) and omega-6 Docosapentaenoic Acid (DPAn-6) (101.5)

Generation and Dietary Modulation of Anti-Inflammatory Electrophilic Omega-3 Fatty Acid Derivatives

Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells

Effect of Eicosapentaenoic Acid Supplementation on Murine Preadipocytes 3T3-L1 Cells Activated with Lipopolysaccharide and/or Tumor Necrosis Factor-α

The Effect of Liposomal Curcumin as an Anti-Inflammatory Strategy on Lipopolysaccharide e from Porphyromonas gingivalis Treated Endothelial Committed Neural Crest Derived Stem Cells: Morphological and Molecular Mechanisms

Synergistic Anti-Inflammatory Effects of Lipophilic Grape Seed Proanthocyanidin and Camellia Oil Combination in LPS-Stimulated RAW264.7 Cells

Enhanced Anti-Inflammatory Effects of DHA and Quercetin in Lipopolysaccharide-Induced RAW264.7 Macrophages by Inhibiting NF-κB and MAPK Activation.

Procyanidin A1 Alleviates Inflammatory Response Induced By Lps Through Nf-Kappa B, Mapk, And Nrf2/Ho-1 Pathways In Raw264.7 Cells